Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
| Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,574,549 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 102 | 132,204 | -0.75% | 2.44% | 8.01% | -3.62% | 17.00% | -4.96% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 2,440 | -0.40% | -3.02% | -13.36% | -40.48% | -32.99% | -36.25% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 3,057 | -2.81% | 4.71% | -11.36% | -20.89% | 25.99% | 169.43% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 996 | -12.78% | -6.44% | -10.47% | -16.79% | 6.21% | 58.70% |
| SAGE Therapeutics, Inc. | SAGE:USASAGE:USA | Stock | 1 | 704 | -2.58% | -1.68% | -10.24% | -47.23% | -37.03% | -77.68% |
| Intra-Cellular Therapies, Inc. | ITCI:USAITCI:USA | Stock | 1 | 6,336 | -2.30% | 0.06% | -9.72% | -11.80% | 18.14% | 3.21% |
| Neumora Therapeutics, Inc. | NMRA:USANMRA:USA | Stock | 1 | 1,541 | 0.42% | 5.22% | -8.34% | -47.56% | -19.42% | N/A |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 585 | -4.97% | -11.23% | -7.74% | 62.13% | 234.15% | 160.95% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 602 | 0.40% | -6.95% | -2.58% | 12.91% | 215.01% | 202.60% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 3,003 | -1.34% | -1.83% | -1.27% | -17.80% | 38.68% | -2.38% |
| REGENXBIO, Inc. | RGNX:USARGNX:USA | Stock | 1 | 784 | -0.12% | 3.56% | -0.74% | -13.75% | -15.22% | -13.85% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 6,869 | -1.36% | -0.58% | -0.26% | -13.75% | -10.51% | -17.28% |
| Cerevel Therapeutics Holdings, Inc. | CERE:USACERE:USA | Stock | 1 | 7,658 | -0.59% | -0.21% | -0.09% | 2.58% | 70.79% | 31.73% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,649 | -0.96% | -3.68% | 0.00% | -12.08% | 12.35% | -19.09% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 1,599 | -0.21% | 0.48% | 0.80% | 3.74% | 4.38% | -16.79% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,086 | -1.27% | 0.42% | 1.64% | -20.53% | 3.34% | -18.68% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
| Alector, Inc. | ALEC:USAALEC:USA | Stock | 1 | 524 | -0.91% | 3.62% | 6.88% | -14.20% | 38.07% | -27.37% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 14,314 | 0.27% | 4.09% | 7.36% | 7.27% | 30.82% | 49.98% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 1,946 | 0.55% | 3.45% | 7.50% | 19.58% | 23.24% | 35.16% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 102 | 132,204 | -0.75% | 2.44% | 8.01% | -3.62% | 17.00% | -4.96% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 752 | -2.36% | 5.52% | 8.46% | 7.37% | 123.84% | 157.62% |
| Cassava Sciences, Inc. | SAVA:USASAVA:USA | Stock | 1 | 1,000 | 7.24% | 14.29% | 9.11% | 2.89% | 5.57% | -6.13% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 1,210 | -3.72% | 5.53% | 9.48% | -18.20% | -34.71% | -69.42% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 655 | -1.02% | -1.64% | 12.60% | 57.89% | 72.13% | 18.42% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 12,414 | -1.02% | -0.33% | 12.72% | -3.50% | 58.33% | -10.28% |
| Longboard Pharmaceuticals, Inc. | LBPH:USALBPH:USA | Stock | 1 | 804 | 0.88% | 2.83% | 14.88% | -2.22% | 343.99% | 117.79% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 3,633 | -1.05% | 5.57% | 16.46% | -5.67% | 28.19% | -0.43% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 2,411 | -3.72% | 6.46% | 17.04% | 21.72% | 183.46% | 110.33% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,689 | -0.39% | -1.20% | 17.22% | 3.07% | 185.20% | 94.52% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 646 | -0.93% | 21.08% | 19.31% | 158.36% | 233.33% | 25.00% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 33,571 | 0.23% | 4.09% | 21.02% | 5.18% | 0.48% | -24.51% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,923 | 1.33% | 12.02% | 23.55% | 24.00% | 13.13% | -32.42% |
| Entrada Therapeutics, Inc. | TRDA:USATRDA:USA | Stock | 1 | 504 | 0.27% | 4.53% | 25.86% | 10.06% | -2.47% | 18.40% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 578 | -1.59% | 32.05% | 28.22% | 43.72% | 96.82% | 341.43% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 2,537 | -2.75% | 2.62% | 34.04% | 27.39% | 65.48% | -43.07% |
* Colors indicate performance relative to the benchmark.